Bioethics and release of incidental genomic findings

  • Thread starter Thread starter jim mcnamara
  • Start date Start date
  • Tags Tags
    Release
AI Thread Summary
The discussion centers on the ethical implications of sharing incidental genomic data with patients, particularly regarding genetic predispositions to diseases. The current policy typically requires patient consent before disclosing such information. However, the conversation highlights the complexity of this issue, given the vast number of diseases with genetic components, including rare conditions like Kearns-Sayre Syndrome and specific risks associated with certain behaviors, like eating raw oysters for those with particular genetic markers.Participants express the need for a standardized ethical approach to inform patients about their genetic data, emphasizing the right to know about potential health risks. The debate also touches on the challenges of ensuring accurate information, as genetic testing can yield false positives or negatives. Some argue for a tiered system of information disclosure, ranging from actionable insights to low-risk genetic markers. Ultimately, the discussion underscores the tension between ethical obligations to inform patients and the complexities of genetic data interpretation.
jim mcnamara
Mentor
Messages
4,789
Reaction score
3,852
This post is in GD because there is no one agreed upon answer even though it deals with genetic data and its use. It is an ethics discussion...

https://science.sciencemag.org/content/373/6555/610
Incidental genomic data means giving patients extra information about what is found in a vounteer patient genome that has potential for disease ( example: like the BRCA gene and breast cancer). As it stands now the policy mostly seems to be to ask the patient if they want the information, and to give it to them only with their consent.

So you understand the magnitude of the problem, consider how many disease processes have a genetic component - literally thousands.

Many are orphan diseases that kind of oddball things, like oyster borne Vibrio (bacterium) disease which may kill someone who has both the wrong gene and has eaten raw oysters that are infected. People without the gene usually will not have a severe problem. Obviously if you don't eat oysters or always eat them cooked - no problem.

Other rare conditions like Kearns-Sayre Syndrome, a genetic defect in mitochondrial DNA, may be partially mediated if caught early and may be a more severe problem otherwise.

https://www.ninds.nih.gov/Disorders/All-Disorders/Kearns-Sayre-Syndrome-Information-Page

The point is: do we or do we not give people information like this as a de facto ethical standard of procedure?
 
Physics news on Phys.org
I saw a documentary today of a film team who accompanied several persons with trisomy for over a year. One woman fought for it shouldn't be allowed to have late abortions if prenatal testing showed trisomy and that the costs for the tests shouldn't be covered by the general health insurance.

She said "I do not want to be aborted. I want to stay in this world." What she really said is, that nobody should ever be allowed to tell her, that she wouldn't be there if the law only had been in place earlier.

Our government has an ethics commission where such topics are discussed. But as usual, the key lies in the appointments. The more we are able to do biochemically, the harder it is to achieve an ethical commitment in time. We cannot debate all topics long and publically enough.

The information about a genetic predisposition shouldn't be a question. A person must have the right to know what others know about them! Ethics can only jump in when the consequences are evaluated, not before. The only other acceptable solution is not to test.
 
jim mcnamara said:
As it stands now the policy mostly seems to be to ask the patient if they want the information, and to give it to them only with their consent.
Is this a routine question on the forms that patients fill out when enrolling in those studies? If so, I think it's covered pretty well. It might be good if there were perhaps different categories of such information, ranging from "You definitely have something that we can treat/prevent right now" to "With this gene you have a low chance of developing this condition".

And is there a chance that such data in the sequencing could be wrong, and cause false worry in the patient? I know with standard tests for certain things, there is usually a chance for false positive/negative that will prompt a second set of tests to verify before starting any treatments...
 
jim mcnamara said:
The point is: do we or do we not give people information like this as a de facto ethical standard of procedure?
I think the information should be offered. I'd want to know, and my wife already knows her situation. Both of us have relatives (parents, aunts/uncles, cousins) with certain illnesses that have some familial/genetic component. I'm aware that some don't want to know.
 
Similar to the 2024 thread, here I start the 2025 thread. As always it is getting increasingly difficult to predict, so I will make a list based on other article predictions. You can also leave your prediction here. Here are the predictions of 2024 that did not make it: Peter Shor, David Deutsch and all the rest of the quantum computing community (various sources) Pablo Jarrillo Herrero, Allan McDonald and Rafi Bistritzer for magic angle in twisted graphene (various sources) Christoph...
Thread 'My experience as a hostage'
I believe it was the summer of 2001 that I made a trip to Peru for my work. I was a private contractor doing automation engineering and programming for various companies, including Frito Lay. Frito had purchased a snack food plant near Lima, Peru, and sent me down to oversee the upgrades to the systems and the startup. Peru was still suffering the ills of a recent civil war and I knew it was dicey, but the money was too good to pass up. It was a long trip to Lima; about 14 hours of airtime...
Back
Top